An Analysis of Variables That Affect Quality of Diabetes Control in Puerto Rico
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 600
- 主要终点
- Blood sugar control
研究概览
简要总结
Project: An analysis of Diabetes Control in Puerto Rico Hypothesis: This project seeks to determine the causes for: i) poor adherence to prescribed treatment by patients, ii) low compliance by providers with national guidelines iii) barriers impose by health insurance in control of diabetes mellitus iv) effectiveness of a disease management program for treatment adherence by patients.
详细描述
Method (s) The study will consist of three phases:
i) assessment phase,
ii) multimedia health education campaign for patients, providers and local health insurances for adherence improvement
iii) reassessment phase.
Target Population:
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 1 and 2 diabetic patients older tha 18 years old
排除标准
- •Hemophilia.
- •Persons younger than
- •Persons in research studies of some drug.
- •Persons using steroids.
- •Patients with acute infections.
- •Pregnant diabetic patients.
结局指标
主要结局
Blood sugar control
时间窗: 2 years
Numbers of Patients with Hg A1C on control (less than 7%). Those with A1c greater than 7% will be considered as not meeting the goal
Blood pressure control
时间窗: 2 years
Blood Pressure Control: Patients will be considered out of blood pressure control if they have a systolic blood pressure greater than 130 mm Hg or a diastolic blood pressure greater than 80 mg Hg
Lipids goal achievement
时间窗: 2 years
The following lipids results will be considered out of goal for this population: LDL cholesterol greater than 100 mg/dL, HDL cholestero lower than 40 mg/dL in male and lower than 50 mg/dL in women, and serum triglycerides greater than 150 mg/dL
次要结局
- Achievement of National Clinical Practice Recommendations among Puerto Rican Population with Diabetes Mellitus(2 years)
研究者
Efrain Rodriguez-Vigil, MD
Medical Director
Center for Diabetes Control, Inc.